Fatal hepatic failure following hepatitis caused by flutamide: A case report

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A seventy-three year-old patient with prostate cancer underwent radical prostatectomy, followed by total androgen brocking therapy using flutamide and LH-RH agonist. As Hepatic dysfunction (GPT = 3,045 IU/l) was noticed by periodic blood analysis, flutamide was stopped and he was hospitalized immediately without any subjective symptoms. Ten days after the admission, he developed massive bleeding from duodenal ulcer, resulting in duodenal perforation. Following the emergency operation, plasma exchange therapy was repeated against serious hepatic dysfunction. However, he was dead of pneumonia two months after the admission. Autopsy revealed biliary congestion in a small liver, although it was not cirrhotic. In our patient, hepatic dysfunction was irreversible and prolonged. We strongly recommend to perform serial liver function test from the start of treatment with flutamide, especially during the initial three months. Flutamide should be stopped promptly if significant liver abnormalities are detected.

Author supplied keywords

Cite

CITATION STYLE

APA

Okaneya, T., Murata, Y., & Kinebuchi, Y. (1999). Fatal hepatic failure following hepatitis caused by flutamide: A case report. Japanese Journal of Urology, 90(5), 590–593. https://doi.org/10.5980/jpnjurol1989.90.590

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free